Information:
Fel:
ID
34220
Beskrivning
BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions; ODM derived from: https://clinicaltrials.gov/show/NCT01426139
Länk
https://clinicaltrials.gov/show/NCT01426139
Nyckelord
Versioner (1)
- 2019-01-15 2019-01-15 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
15 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Coronary Artery Disease NCT01426139
Eligibility Coronary Artery Disease NCT01426139
- StudyEvent: Eligibility
Similar models
Eligibility Coronary Artery Disease NCT01426139
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
subject has provided a written informed consent
boolean
ID.2
Item
single de novo lesion with ≥ 50% and <100% stenosis in up to 2 coronary arteries
boolean
ID.3
Item
the target lesion length is ≤ 26 mm
boolean
ID.4
Item
the target reference vessel diameter is ≥ 2.0 mm and ≤ 4.0 mm
boolean
ID.5
Item
main exclusion criteria:
boolean
ID.6
Item
evidence of myocardial infarction within 72 hours prior to index procedure
boolean
ID.7
Item
unprotected left main coronary artery disease (stenosis >50%)
boolean
ID.8
Item
three-vessel coronary artery disease at time of procedure thrombus in target vessel
boolean
ID.9
Item
target lesion involves a side branch > 2.0 mm in diameter
boolean
ID.10
Item
heavily calcified lesion
boolean
ID.11
Item
target lesion is located in or supplied by an arterial or venous bypass graft
boolean